Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.

Small cell lung cancer 1973–1983: Early progress and recent obstacles

1984 • 219 citations

An overview of prognostic factors in small cell lung cancer

1990 • 206 citations

Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

1987 • 200 citations

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

1985 • 151 citations

Radiation therapy of cerebral metastases: a randomized prospective clinical trial

1977 • 129 citations

Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.

1989 • 97 citations

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

1987 • 96 citations

Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons?

1990 • 74 citations

A review of platinum complex biochemistry suggests a rationale for combined platinum-radiotherapy

1979 • 65 citations

Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus

1989 • 57 citations

Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer

1987 • 31 citations

Carboplatin in lung cancer

1989 • 3 citations